• Muvon

Translation and automation hurdles for cell therapies

Informative article published in BioInsights, written by our CSO Jenny Prange and our innovation manager Beatrix Rauch Schmid.


This viewpoint gives a short summary about what needs to be considered to transfer an autologous celltherapy from bench to bedside and what automation challenges could arise during future development.


Read the full article here.



119 views0 comments